Evidence map›Paper›PMID 34021488›Full record

ReviewSports medicine (Auckland, N.Z.)2021

Crossing the Golden Training Divide: The Science and Practice of Training World-Class 800- and 1500-m Runners.

Thomas Haugen, Øyvind Sandbakk, Eystein Enoksen, Stephen Seiler, Espen Tønnessen

Abstract readReview
In one paragraph

Review in Sports medicine (Auckland, N.Z.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Thomas HaugenSchool of Health Sciences, Kristiania University College, Sentrum, PB 1190, 0107, Oslo, Norway. thomas.haugen@kristiania.no.ORCID 0000-0001-5929-0389
Øyvind SandbakkDepartment of Neuromedicine and Movement Science, Centre for Elite Sports Research, Norwegian University of Science and Technology, 7491, Trondheim, Norway.
Eystein EnoksenDepartment of Physical Performance, Norwegian School of Sport Sciences, 0806, Oslo, Norway.
Stephen SeilerFaculty of Health and Sport Sciences, University of Agder, PB 422, 4604, Kristiansand, Norway.
Espen TønnessenSchool of Health Sciences, Kristiania University College, Sentrum, PB 1190, 0107, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite an increasing amount of research devoted to middle-distance training (herein the 800 and 1500 m events), information regarding the training methodologies of world-class runners is limited. Therefore, the objective of this review was to integrate scientific and best practice literature and outline a novel framework for understanding the training and development of elite middle-distance performance. Herein, we describe how well-known training principles and fundamental training characteristics are applied by world-leading middle-distance coaches and athletes to meet the physiological and neuromuscular demands of 800 and 1500 m. Large diversities in physiological profiles and training emerge among middle-distance runners, justifying a categorization into types across a continuum (400-800 m types, 800 m specialists, 800-1500 m types, 1500 m specialists and 1500-5000 m types). Larger running volumes (120-170 vs. 50-120 km·week

Indexed as

Plyometric ExerciseRunningAnaerobic ThresholdAthletesHumansLactic AcidMaleOxygen ConsumptionLactic Acid

Identifiers

PMID34021488
PMCPMC8363530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.